Common Contracts
4 similar Sublicense Agreement contracts by Evommune, Inc.
Certain identified information has been omitted from this exhibit because it is both (i) not material and (ii) of the type that the Registrant treats as private or confidential. Such omitted information is indicated by brackets (“[***]”) in this...Sublicense Agreement • October 9th, 2025 • Evommune, Inc. • Pharmaceutical preparations • Delaware
This Sublicense Agreement (this “Agreement”), dated as of September 26, 2023 (the “Effective Date”), is made by and between Evommune, Inc., a Delaware corporation (“Evommune”), and Maruho Co., Ltd., a company organized under the laws of Japan (“Maruho”). Evommune and Maruho are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
Certain identified information has been omitted from this exhibit because it is both (i) not material and (ii) of the type that the Registrant treats as private or confidential. Such omitted information is indicated by brackets (“[***]”) in this...Sublicense Agreement • October 9th, 2025 • Evommune, Inc. • Pharmaceutical preparations • Delaware
This Sublicense Agreement (this “Agreement”), dated as of March 19, 2024 (the “Effective Date”), is made by and between Evommune, Inc., a Delaware corporation (“Evommune”), and Maruho Co., Ltd., a company organized under the laws of Japan (“Maruho”). Evommune and Maruho are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
Certain identified information has been omitted from this exhibit because it is both (i) not material and (ii) of the type that the Registrant treats as private or confidential. Such omitted information is indicated by brackets (“[***]”) in this...Sublicense Agreement • July 18th, 2025 • Evommune, Inc. • Pharmaceutical preparations • Delaware
This Sublicense Agreement (this “Agreement”), dated as of March 19, 2024 (the “Effective Date”), is made by and between Evommune, Inc., a Delaware corporation (“Evommune”), and Maruho Co., Ltd., a company organized under the laws of Japan (“Maruho”). Evommune and Maruho are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
Certain identified information has been omitted from this exhibit because it is both (i) not material and (ii) of the type that the Registrant treats as private or confidential. Such omitted information is indicated by brackets (“[***]”) in this...Sublicense Agreement • July 18th, 2025 • Evommune, Inc. • Pharmaceutical preparations • Delaware
This Sublicense Agreement (this “Agreement”), dated as of September 26, 2023 (the “Effective Date”), is made by and between Evommune, Inc., a Delaware corporation (“Evommune”), and Maruho Co., Ltd., a company organized under the laws of Japan (“Maruho”). Evommune and Maruho are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”